Hospital Epidemiology Service and the Office of the Deputy Director for Clinical Care, Clinical Center, National Institutes of Health, Bethesda, Maryland.
Clin Infect Dis. 2013 Dec;57(11):1593-9. doi: 10.1093/cid/cit531. Epub 2013 Aug 9.
In 2011, the National Institutes of Health Clinical Center experienced a cluster of infection and colonization caused by carbapenem-resistant Klebsiella pneumoniae among profoundly immunocompromised inpatients. This manuscript describes the approach and interventions that were implemented in an attempt to curtail the cluster. Interventions employed included engagement of all stakeholders involved in care of at-risk patients; detailed and frequent communication with hospital staff about issues relating to the outbreak; aggressive microbial surveillance; use of techniques that facilitate rapid identification of resistant organisms; rapid characterization of resistance mechanisms; whole-genome sequencing of outbreak isolates to characterize the spread and to investigate mechanisms of healthcare-associated spread; implementation of enhanced contact precautions for all infected or colonized patients; geographic and personnel cohorting; daily chlorhexidine gluconate baths; dedicating equipment to be used solely for cohorted patients and aggressive decontamination of equipment that had to be reused on uncohorted patients; monitoring adherence to infection control precautions, including unwavering attention to adherence to appropriate hand hygiene procedures; and attention to the details of environmental decontamination. In addition, the manuscript discusses some of the challenges associated with managing such an event, as well as a few of the unanticipated consequences associated with the aftermath of the case cluster.
2011 年,美国国立卫生研究院临床中心(National Institutes of Health Clinical Center)经历了一起由耐碳青霉烯类肺炎克雷伯菌(carbapenem-resistant Klebsiella pneumoniae)引起的感染和定植集群,涉及严重免疫功能低下的住院患者。本文档描述了为遏制集群而实施的方法和干预措施。所采用的干预措施包括:让所有参与高危患者护理的利益相关者参与其中;与医院工作人员就与疫情相关的问题进行详细和频繁的沟通;积极进行微生物监测;采用有助于快速识别耐药生物的技术;快速分析耐药机制;对疫情分离株进行全基因组测序,以描述传播情况并研究医疗保健相关传播的机制;对所有感染或定植的患者实施强化接触预防措施;进行地理和人员分组;每天使用洗必泰葡萄糖酸盐浴液;为分组患者专用设备,并对必须重复用于未分组患者的设备进行强力消毒;监测感染控制预防措施的遵守情况,包括始终关注适当的手部卫生程序的遵守情况;以及关注环境消毒的细节。此外,本文档还讨论了与管理此类事件相关的一些挑战,以及与病例集群事件后相关的一些意外后果。